Tirzepatide is a dual agonist that activates both GLP-1 and GIP (glucose-dependent insulinotropic polypeptide) receptors, while other medications in this class activate only GLP-1 receptors
A three-month bundle lowers it to $149 each month ($447 paid up front), and a 12-month bundle drops it to $99 each month ($1,188 paid up front)
Schwartz is a leading researcher in the field of metabolic regulation and GLP-1
The GLP-1 receptor exists in multiple tissues, including immune cells, and theoretical concerns exist about GLP-1 medications potentially modulating immune responses
Promotion of insulin secretion by glucagon
doi: 10.1016/j.neuroscience.2015.06.054 Summary Keywords Parkinsons disease, diabetes, glucagon-like peptide 1, insulin, energy metabolism, neuroprotection Citation Lv D, Feng P, Guan X, Liu Z, Li D, Xue C, Bai B and Hlscher C (2024) Neuroprotective effects of GLP-1 class drugs in Parkinsons disease